Results 181 to 190 of about 34,412 (225)

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial. [PDF]

open access: yesNat Commun
Lee CK   +34 more
europepmc   +1 more source

Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer. [PDF]

open access: yesCancer Immunol Immunother
Takei S   +9 more
europepmc   +1 more source

Cytoplasmic poly-adenosine binding proteins modulate susceptibility of mRNAs to Pumilio-mediated decay. [PDF]

open access: yesNucleic Acids Res
McKenney KM   +6 more
europepmc   +1 more source

A historical review of mycosis fungoides: from Alibert to mogamulizumab. [PDF]

open access: yesSkin Health Dis
Johnson NA   +4 more
europepmc   +1 more source

The changing immune landscape of innate-like T cells and other innate cells throughout life. [PDF]

open access: yesImmunol Cell Biol
Taheri M   +9 more
europepmc   +1 more source

C-C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice. [PDF]

open access: yesElife
Tanaka T   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy